| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6090650 | Nutrition | 2008 | 11 Pages |
Abstract
Weight regain after RYGB occurs in approximately 20% of patients and constitutes a serious complication. Weight regain-promoting consequences are attributed to a failure to sustain elevated plasma PYY concentrations, indicating that combining RYGB with pharmacologic stimulation of PYY secretion in patients after RYGB who exhibit inadequate PYY concentration may increase long-term success of surgical weight reduction in morbidly obese adults.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Michael M. M.D., Ph.D., Michael J. Ph.D., Frank A. Ph.D.,